The impact of driving time, distance, and socioeconomic factors on outcomes of patients with locally advanced rectal cancer

por Gotfrit, Joanna, Thangarasa, Tharshika, Dudani, Shaan, Goodwin, Rachel, Tang, Patricia A., Monzon, Jose, Dennis, Kristopher, Cheung, Winson Y., Marginean, Horia, Vickers, Michael
Publicado 2020

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiat...

por Dudani, Shaan, Marginean, Horia, Tang, Patricia A., Monzon, Jose G., Raissouni, Soundouss, Asmis, Timothy R., Goodwin, Rachel A., Gotfrit, Joanna, Cheung, Winson Y., Vickers, Michael M.
Publicado 2019

Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care

por Sheffield, Brandon S., Beharry, Andrea, Diep, Joanne, Perdrizet, Kirstin, Iafolla, Marco A. J., Raskin, William, Dudani, Shaan, Brett, Mary Anne, Starova, Blerta, Olsen, Brian, Cheema, Parneet K.
Publicado 2022

Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review

por Fernandes, Ricardo, Mazzarello, Sasha, Stober, Carol, Ibrahim, Mohamed F.K., Dudani, Shaan, Perdrizet, Kirstin, Majeed, Habeeb, Vandermeer, Lisa, Shorr, Risa, Hutton, Brian, Fergusson, Dean, Gyawali, Bishal, Clemons, Mark
Publicado 2017

The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation

por Dudani, Shaan, Marginean, Horia, Gotfrit, Joanna, Tang, Patricia A., Monzon, Jose Gerard, Dennis, Kristopher, Kennecke, Hagen F., Powell, Erin D., Babak, Sam, Cheung, Winson Y., Vickers, Michael M.
Publicado 2021

Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma

por Gupta, Alind, Arora, Paul, Brenner, Darren, Vanderpuye-Orgle, Jacqueline, Boyne, Devon J., Edmondson-Jones, Mark, Parkhomenko, Elena, Stevens, Warren, Dudani, Shaan, Heng, Daniel Y. C., Wagner, Samuel, Borrill, John, Wu, Elise
Publicado 2021

A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre

por Cheema, Parneet K., Iafolla, Marco A. J., Nematollahi, Massey, Berco, FeRevelyn, Kaushik, Deepanjali, Matthews, Priscilla, Raskin, William R., Perdrizet, Kirstin A., Dudani, Shaan, Husain, Juhi, Balcewicz, Margaret, Kuruvilla, Philip G., Reingold, Stephen M., Conter, Henry J.
Publicado 2022

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma

por Abou Alaiwi, Sarah, Xie, Wanling, Nassar, Amin H, Dudani, Shaan, Martini, Dylan, Bakouny, Ziad, Steinharter, John A, Nuzzo, Pier Vitale, Flippot, Ronan, Martinez-Chanza, Nieves, Wei, Xiao, McGregor, Bradley A, Kaymakcalan, Marina D, Heng, Daniel Y C, Bilen, Mehmet A, Choueiri, Toni K, Harshman, Lauren C
Publicado 2020

Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

por Dudani, Shaan, de Velasco, Guillermo, Wells, J. Connor, Gan, Chun Loo, Donskov, Frede, Porta, Camillo, Fraccon, Anna, Pasini, Felice, Lee, Jae Lyun, Hansen, Aaron, Bjarnason, Georg A., Beuselinck, Benoit, Pal, Sumanta K., Yuasa, Takeshi, Kroeger, Nils, Kanesvaran, Ravindran, Reaume, M. Neil, Canil, Christina, Choueiri, Toni K., Heng, Daniel Y. C.
Publicado 2021

Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Rena...

por Gan, Chun Loo, Dudani, Shaan, Wells, J. Connor, Donskov, Frede, Pal, Sumanta K., Dizman, Nazli, Rathi, Nityam, Beuselinck, Benoit, Yan, Flora, Lalani, Aly‐Khan A., Hansen, Aaron, Szabados, Bernadett, de Velasco, Guillermo, Tran, Ben, Lee, Jae Lyun, Vaishampayan, Ulka N., Bjarnason, Georg A., Subasri, Mathushan, Choueiri, Toni K., Heng, Daniel Y. C.
Publicado 2021

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

por Bakouny, Ziad, Braun, David A., Shukla, Sachet A., Pan, Wenting, Gao, Xin, Hou, Yue, Flaifel, Abdallah, Tang, Stephen, Bosma-Moody, Alice, He, Meng Xiao, Vokes, Natalie, Nyman, Jackson, Xie, Wanling, Nassar, Amin H., Abou Alaiwi, Sarah, Flippot, Ronan, Bouchard, Gabrielle, Steinharter, John A., Nuzzo, Pier Vitale, Ficial, Miriam, Sant’Angelo, Miriam, Forman, Juliet, Berchuck, Jacob E., Dudani, Shaan, Bi, Kevin, Park, Jihye, Camp, Sabrina, Sticco-Ivins, Maura, Hirsch, Laure, Baca, Sylvan C., Wind-Rotolo, Megan, Ross-Macdonald, Petra, Sun, Maxine, Lee, Gwo-Shu Mary, Chang, Steven L., Wei, Xiao X., McGregor, Bradley A., Harshman, Lauren C., Genovese, Giannicola, Ellis, Leigh, Pomerantz, Mark, Hirsch, Michelle S., Freedman, Matthew L., Atkins, Michael B., Wu, Catherine J., Ho, Thai H., Linehan, W. Marston, McDermott, David F., Heng, Daniel Y. C., Viswanathan, Srinivas R., Signoretti, Sabina, Van Allen, Eliezer M., Choueiri, Toni K.
Publicado 2021